Brendel Financial Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,281	Closed	-$100K	–	93
2023 Q4	$100K	Sell	18,281 -844	-4%	-$4.62K	0.07%	90
2023 Q3	$72K	Buy	+19,125	New	+$72K	0.11%	44